Showing results (11-20 of 113) with videos related to

Sort By:
Pageof 12
Biochemical and Biophysical Research Communications|June 9, 2009
TGF-beta is necessary for induction of IL-23R and Th17 differentiation by IL-6 and IL-23Noriko Morishima, Izuru Mizoguchi, Kiyoshi Takeda, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 23, 2006
IL-27 induces Th1 differentiation via p38 MAPK/T-bet- and intercellular adhesion molecule-1/LFA-1/ERK1/2-dependent pathwaysToshiyuki Owaki, Masayuki Asakawa, Fumio Fukai, et al.
Medicine|September 15, 2018
Case report: two cases of extremely rare primary pure squamous cell carcinoma of the breastToshihiko Yoneto, Kenichiro Hasumi, Takayuki Yoshimoto, et al.
Regenerative Therapy|April 14, 2025
Amelioration of female menopausal syndrome by intravenous administration of autologous menstrual blood-derived stem cellsHiromi Izawa, Charlie Xiang, Seiji Ogawa, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 20, 2007
IL-27 suppresses Th2 cell development and Th2 cytokines production from polarized Th2 cells: a novel therapeutic way for Th2-mediated allergic inflammationTomohiro Yoshimoto, Takayuki Yoshimoto, Koubun Yasuda, et al.
Nature Medicine|March 18, 2008
Interferon-gamma is a therapeutic target molecule for prevention of postoperative adhesion formationHisashi Kosaka, Tomohiro Yoshimoto, Takayuki Yoshimoto, et al.
Immunotherapy|September 30, 2010
Antimelanoma immunotherapy: clinical and preclinical applications of IL-12 family membersHiroshi Nagai, Shuntaro Oniki, Susumu Fujiwara, et al.
Biochemical and Biophysical Research Communications|December 21, 2004
No inhibition of IL-27 signaling by soluble gp130Jürgen Scheller, Björn Schuster, Christoph Hölscher, et al.
Immunotherapy|July 20, 2010
Interleukins and cancer immunotherapyTakayuki Yoshimoto, Noriko Morishima, Masae Okumura, et al.
Pageof 12